Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
Authors
Keywords
-
Journal
Oncology Letters
Volume 24, Issue 2, Pages -
Publisher
Spandidos Publications
Online
2022-06-22
DOI
10.3892/ol.2022.13395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
- (2022) Shaloam Dasari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
- (2021) Qingrong Li et al. OncoTargets and Therapy
- Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis
- (2021) Yuxue Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- (2021) Robert Csaba Kiss et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
- (2020) Jiabei Zhou et al. Frontiers in Pharmacology
- The birth of artemisinin
- (2020) Nan Ma et al. PHARMACOLOGY & THERAPEUTICS
- Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
- (2020) Xiao Chen et al. Oncology Letters
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo
- (2019) Kensaku Abe et al. BMC CANCER
- Natural products: An upcoming therapeutic approach to cancer
- (2019) Sayanta Dutta et al. FOOD AND CHEMICAL TOXICOLOGY
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
- (2019) Simona Gurzu et al. Biomed Research International
- Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO3 Mineralized Metal-Organic Framework
- (2019) Xiuyan Wan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Challenges in liver cancer and possible treatment approaches
- (2019) David Anwanwan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents
- (2019) Neife Aparecida Guinaim dos Santos et al. FOOD AND CHEMICAL TOXICOLOGY
- Natural compounds and combination therapy in colorectal cancer treatment
- (2018) A. Rejhová et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dihydroartemisinin induced caspase-dependent apoptosis through inhibiting the specificity protein 1 pathway in hepatocellular carcinoma SK-Hep-1 cells
- (2018) Eunji Im et al. LIFE SCIENCES
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- Nanostructured Dihydroartemisinin Plus Epirubicin Liposomes Enhance Treatment Efficacy of Breast Cancer by Inducing Autophagy and Apoptosis
- (2018) Ying-Jie Hu et al. Nanomaterials
- Cisplatin induced arrhythmia; electrolyte imbalance or disturbance of the SA node?
- (2017) Rabbab Oun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
- (2017) Hong Jin et al. Molecular Medicine Reports
- Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives
- (2017) Liping Wu et al. PLoS One
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- In vitro and in vivo inhibition of tumor cell viability by combined dihydroartemisinin and doxorubicin treatment, and the underlying mechanism
- (2016) Xiang Tai et al. Oncology Letters
- A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma
- (2015) Yan Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Novel anti-malarial combinations and their toxicity
- (2014) Brian Angus Expert Review of Clinical Pharmacology
- Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: A retrospective evaluation
- (2013) LAURA ASTOLFI et al. ONCOLOGY REPORTS
- Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro
- (2012) HAITING MAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Artemisinin: Discovery from the Chinese Herbal Garden
- (2011) Louis H. Miller et al. CELL
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
- (2011) Youyou Tu NATURE MEDICINE
- Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms
- (2009) Rong Zhang et al. TOXICOLOGY LETTERS
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now